Equillium, Inc.
EQ- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001746466
No open-market purchases or sales by Equillium, Inc. insiders were filed in the last 90 days; 60 institutions reported holding it in 13F filings for Q2 2026, worth $133.0M in total; no superinvestor holds it.
13F holders, Q4 2025
Institutional positions in Equillium, Inc. as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 36
- −3 vs. Q3 2025
- Shares held
- 35.3M
- +7.46M (+26.8%) vs. Q3 2025
- Total value
- $54.7M
- +$14.9M (+37.4%) vs. Q3 2025
- New holders
- 8
- 15 more added
- Sold out
- 11
- 7 more reduced
1 institution that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting EQ on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 60 | $133.0M |
| Q1 2026 | 50 | $81.0M |
| Q4 2025 | 36 | $54.7M |
| Q3 2025 | 40 | $42.4M |
| Q2 2025 | 27 | $2.74M |
| Q1 2025 | 24 | $3.39M |
| Q4 2024 | 26 | $6.52M |
| Q3 2024 | 26 | $7.25M |
| Q2 2024 | 25 | $6.15M |
| Q1 2024 | 28 | $20.5M |
| Q4 2023 | 25 | $6.85M |
| Q3 2023 | 25 | $6.75M |
| Q2 2023 | 27 | $7.44M |
| Q1 2023 | 28 | $7.86M |
| Q4 2022 | 31 | $13.3M |
| Q3 2022 | 30 | $28.4M |
| Q2 2022 | 25 | $25.6M |
| Q1 2022 | 30 | $39.7M |
| Q4 2021 | 26 | $27.0M |
| Q3 2021 | 22 | $49.9M |
| Q2 2021 | 28 | $41.9M |
| Q1 2021 | 33 | $54.6M |
Institutions, Q4 2025
Shares, value and share of portfolio for each institution holding Equillium, Inc.; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Jones Financial Companies LLLP | 250 | $388 | 0.00% | +250 | New |
| SBI Securities Co., Ltd. | 283 | $439 | 0.00% | −162−36.4% | Reduced |
| Bank of America Corp | 295 | $457 | 0.00% | +21+7.7% | Added |
| UBS Group AG | 920 | $1.43K | 0.00% | −27,110−96.7% | Reduced |
| Wells Fargo & Company | 1,000 | $1.55K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 4,070 | $6.31K | 0.00% | −2,336−36.5% | Reduced |
| Coastal Bridge Advisors, LLC | 10,500 | $16.3K | 0.00% | +10,500 | New |
| Apollon Wealth Management, LLC | 13,875 | $21.5K | 0.00% | 00.0% | Unchanged |
| Tudor Investment Corp Et Al | 20,100 | $31.2K | 0.00% | +20,100 | New |
| Schonfeld Strategic Advisors LLC | 25,381 | $39.3K | 0.00% | −99,442−79.7% | Reduced |
| Morgan Stanley | 35,734 | $55.4K | 0.00% | +25,649+254.3% | Added |
| Two Sigma Advisers, LP | 44,100 | $68.4K | 0.00% | +44,100 | New |
| AlphaCore Capital LLC | 52,345 | $81.1K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 79,734 | $124.0K | 0.00% | +79,734 | New |
| Northern Trust Corp | 88,529 | $137.2K | 0.00% | +53,510+152.8% | Added |
| Persistent Asset Partners Ltd | 93,123 | $144.3K | 0.07% | +24,132+35.0% | Added |
| Boothbay Fund Management, LLC | 93,211 | $144.5K | 0.00% | −28,742−23.6% | Reduced |
| Jane Street Group, LLC | 100,850 | $156.3K | 0.00% | +100,850 | New |
| BlackRock, Inc. | 126,053 | $195.4K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 155,420 | $240.9K | 0.00% | +17,900+13.0% | Added |
| Susquehanna International Group, LLP | 185,669 | $287.8K | 0.00% | +185,669 | New |
| Ikarian Capital, LLC | 303,555 | $470.5K | 0.06% | −28,742−8.6% | Reduced |
| Two Sigma Investments, LP | 324,610 | $503.1K | 0.00% | +191,606+144.1% | Added |
| Geode Capital Management, LLC | 345,310 | $535.3K | 0.00% | +34,491+11.1% | Added |
| Diadema Partners LP | 347,393 | $538.5K | 0.32% | +47,393+15.8% | Added |
| Hudson Bay Capital Management LP | 428,538 | $664.2K | 0.00% | +150,000+53.9% | Added |
| Cantor Fitzgerald, L. P. | 562,643 | $872.1K | 0.03% | +137,643+32.4% | Added |
| Renaissance Technologies LLC | 733,226 | $1.14M | 0.00% | +118,303+19.2% | Added |
| Vanguard Group Inc | 1,920,423 | $2.98M | 0.00% | +606,477+46.2% | Added |
| Balyasny Asset Management LLC | 2,076,250 | $3.22M | 0.01% | +72,602+3.6% | Added |
| Standard Life Aberdeen plc | 2,366,688 | $3.67M | 0.01% | +1,987,162+523.6% | Added |
| Woodline Partners LP | 3,500,901 | $5.43M | 0.02% | −7,870−0.2% | Reduced |
| Decheng Capital LLC | 4,447,308 | $6.89M | 0.93% | 00.0% | Unchanged |
| Adage Capital Partners GP, L.L.C. | 5,329,416 | $8.26M | 0.01% | 00.0% | Unchanged |
| ADAR1 Capital Management, LLC | 5,608,078 | $8.69M | 0.65% | +48,090+0.9% | Added |
| Janus Henderson Group PLC | 5,862,212 | $9.06M | 0.00% | +5,862,212 | New |
| StemPoint Capital LP | 0 | $0 | 0.00% | −1,908,935−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −85,557−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −41,220−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −39,739−100.0% | Sold out |
| Prudential Financial Inc | 0 | $0 | 0.00% | −28,300−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −24,356−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −23,779−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −10,544−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −1,922−100.0% | Sold out |
| Rise Advisors, LLC | 0 | $0 | 0.00% | −263−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −200−100.0% | Sold out |
| Takeda Pharmaceutical Co Ltd | – | – | – | – | Not filed |